Inherited cardiomyopathies.

Inherited cardiomyopathies.

Show other versions (3)

Bibliographic Details
Main Authors:	Watkins, H, Ashrafian, H, Redwood, C
Format:	Journal article
Language:	English
Published:	2011

Similar Items

Inherited cardiomyopathies.
by: Watkins, H, et al.
Published: (2011)

Inherited cardiomyopathies
by: Harper, A, et al.
Published: (2014)

Inherited cardiomyopathies
by: Harper, A, et al.
Published: (2014)

Alpha-tropomyosin mutations in inherited cardiomyopathies.
by: Redwood, C, et al.
Published: (2013)

Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion.
by: Ashrafian, H, et al.
Published: (2003)

Mutation analysis of genes encoding subunits of AMP-activated protein kinase (AMPK) in inherited cardiomyopathies
by: Blair, E, et al.
Published: (2002)

Mutation analysis of genes encoding Subunits of AMP-activated protein kinase (AMPK) in inherited cardiomyopathies
by: Oliveira, M, et al.
Published: (2002)

Myocardial dysfunction in hypertrophic cardiomyopathy.
by: Ashrafian, H, et al.
Published: (2001)

Mutation analysis of AMP-activated protein kinase subunits in inherited cardiomyopathies: implications for kinase function and disease pathogenesis.
by: Oliveira, S, et al.
Published: (2003)

DEVELOPMENT AND CHARACTERISATION OF A NOVEL KNOCK-IN MODEL OF PRKAG2 CARDIOMYOPATHY
by: Yavari, A, et al.
Published: (2009)

Metabolic perturbations in the pathogenesis of hypertrophic cardiomyopathy
by: Ashrafian, H, et al.
Published: (2005)

Genetic cardiomyopathies causing heart failure.
by: Cahill, T, et al.
Published: (2013)

The genetics of hypertrophic cardiomyopathy: Teare redux.
by: Watkins, H, et al.
Published: (2008)

Ascertainment strategies and genotype:phenotype correlations in hypertrophic cardiomyopathy.
by: Blair, E, et al.
Published: (2003)

Adaptation and validation of the ACMG/AMP variant classification framework for MYH7-associated inherited cardiomyopathies: recommendations by ClinGen’s Inherited Cardiomyopathy Expert Panel
by: Kelly, M, et al.
Published: (2018)

Exercise-induced ventricular dysfunction in hypertrophic cardiomyopathy: stunning by any other name?
by: Ashrafian, H, et al.
Published: (2008)

Cardiomyopathies
by: Chan, K, et al.
Published: (2018)

Disease pathways and novel therapeutic targets in hypertrophic cardiomyopathy.
by: Ashrafian, H, et al.
Published: (2011)

A novel mutation in phospholamban causes a mixed hypertrophic and dilated cardiomyopathy phenotype with autosomal dominant inheritance
by: Carballo, S, et al.
Published: (2004)

Altered regulatory properties of human cardiac troponin I mutants that cause hypertrophic cardiomyopathy.
by: Elliott, K, et al.
Published: (2000)

Reviews of translational medicine and genomics in cardiovascular disease: new disease taxonomy and therapeutic implications cardiomyopathies: therapeutics based on molecular phenotype.
by: Ashrafian, H, et al.
Published: (2007)

Investigation of troponin I mutations causing familial hypertrophic cardiomyopathy
by: Abdulrazzak, H, et al.
Published: (2001)

Effects of hypertrophic cardiomyopathy mutations in troponin I on contractility of skinned cardiac muscle fibres
by: Burton, D, et al.
Published: (2002)

Altered inhibitory and troponin C-binding activities in cardiac troponin I mutants known to cause hypertrophic cardiomyopathy
by: Elliott, K, et al.
Published: (2000)

Refining the genetic architecture of inherited cardiomyopathies through case-control analyses
by: Thomson, K
Published: (2018)

Functional effects of mutations in troponin T and tropomyosin which cause dilated cardiomyopathy
by: Robinson, P, et al.
Published: (2003)

Sudden death in hypertrophic cardiomyopathy.
by: Watkins, H
Published: (2000)

Investigating the Effect of Cardiomyopathy-Causing Mutations in Cardiac Troponin-T on Calcium Buffering In Situ
by: Robinson, P, et al.
Published: (2010)

Functional analysis of hypertrophic cardiomyopathy missense mutations in the light meromyosin region of beta myosin heavy chain
by: Redwood, C, et al.
Published: (2003)

Comparison of the functional effects of mutations in troponin T which cause dilated and hypertrophic cardiomyopathies
by: Robinson, P, et al.
Published: (2002)

Using fluorescence emission spectroscopy to asses the Ca2+ affinity of reconstituted troponin and thin filaments containing cardiomyopathy causing mutations of troponin and alpha-tropomyosin
by: Robinson, P, et al.
Published: (2007)

Dilated and hypertrophic cardiomyopathy mutations in troponin and alpha-tropomyosin have opposing effects on the calcium affinity of cardiac thin filaments.
by: Robinson, P, et al.
Published: (2007)

Alterations in thin filament regulation induced by a human cardiac troponin T mutant that causes dilated cardiomyopathy are distinct from those induced by troponin T mutants that cause hypertrophic cardiomyopathy.
by: Robinson, P, et al.
Published: (2002)

Identification and functional analysis of cardiac troponin I as a novel disease gene in autosomal dominant familial dilated cardiomyopathy
by: Carballo, S, et al.
Published: (2006)

Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis.
by: Blair, E, et al.
Published: (2001)

Mutations in the gamma2 subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis.
by: Blair, E, et al.
Published: (2001)

Dilated cardiomyopathy and the desmin gene.
by: Mayosi, B, et al.
Published: (2000)

Familial dilated cardiomyopathy caused by an alpha-tropomyosin mutation: the distinctive natural history of sarcomeric dilated cardiomyopathy.
by: Lakdawala, N, et al.
Published: (2010)

A troponin I mutant known to cause hypertrophic cardiomyopathy shows reduced inhibition of Ca2+ independent tension
by: Burton, D, et al.
Published: (2000)

Regression of dilated-hypokinetic hypertrophic cardiomyopathy by biventricular cardiac pacing.
by: Ashrafian, H, et al.
Published: (2007)